JANUX THERAPEUTICS, INC. (JANX)
Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
Consensus Cloud Solutions, Inc. Reports Second Quarter 2026 Results; Reaffirms Full Year 2026 and Releases Q3 2026 Guidance; Increases Stock Buyback Program to $200 Million
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SIGA - SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026
Halozyme - HALOZYME REPORTS RECORD SECOND QUARTER 2026 RESULTS, BEATS ESTIMATES AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE
Maravai LifeSciences Reports Second Quarter 2026 Financial Results
Ross Stores, Inc. Announces Second Quarter 2026 Earnings Release and Conference Call
Agomab Reports Half Year 2026 Financial Results and Confirms 2026 Outlook
Progyny, Inc. Announces Second Quarter 2026 Results
Voyager Reports Second Quarter 2026 Financial and Operating Results
Outset Medical Reports Second Quarter 2026 Results
Research Frontiers Reports Second Quarter 2026 Financial Results and Will Host a Conference Call at 4:30 p.m. Today
Gevo Reports Second Quarter Results and Raises Financial Expectations for Full-Year 2026
BRC Group Holdings, Inc. Reports Second Quarter 2026 Financial Results
Sezzle Reports Second Quarter 2026 Results